Other languages Roivant Sciences Ltd.

Equities

ROIV

BMG762791017

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
10.88 ^USD	-0.18%		+5.02%	-3.12%

Apr. 05	Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit	MT
Apr. 04	Moderna Suffers Setback in Lawsuit by Arbutus	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit	Apr. 05
Moderna Suffers Setback in Lawsuit by Arbutus	Apr. 04
Moderna shares fall after judge sides with Arbutus in patent fight	Apr. 03
Roivant Sciences Says Study of Potential Uveitis Treatment Meets Endpoints; Launches Stock Repurchase; Shares Rise	Apr. 02
Roivant Sciences Ltd. announces an Equity Buyback for $1,500 million worth of its shares.	Apr. 02
Roivant's anti-inflammatory drug succeeds in mid-stage study	Apr. 02
Roivant and Priovant Therapeutics Announce Positive Results from the Phase 2 Study for Brepocitinib in NIU	Apr. 02
Roivant Sciences Ltd. authorizes a Buyback Plan.	Apr. 01
MÄRKTE USA/Freundlich - Sinkende Marktzinsen stützen Aktien	Mar. 27
MÄRKTE USA/Freundlich - Merck nach Medikamentenzulassung gesucht	Mar. 27
Sunrun, Roivant Shares Rise Ahead of Inclusion in S&P SmallCap, MidCap Indexes	Mar. 27
MÄRKTE USA/Wall Street mit freundlichem Beginn	Mar. 27
MÄRKTE USA/Wall Street vor freundlichem Beginn	Mar. 27
Roivant Sciences Swings to Fiscal Q3 Earnings as Net Revenue Rises	Feb. 13
Roivant Sciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 13
Stocks Decline Pre-Bell Ahead of Key Inflation Data; Asia Mixed, Europe Down	Feb. 13
Roivant Sciences Insider Sold Shares Worth $1,058,694, According to a Recent SEC Filing	Feb. 12
Roivant Sciences Insider Sold Shares Worth $33,150,000, According to a Recent SEC Filing	Jan. 03
Roivant Sciences Completes Sale of Telavant to Roche	Dec. 14
Roche Holding AG completed the acquisition of Telavant Holdings, Inc. from Roivant Sciences Ltd. and Pfizer Inc..	Dec. 13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Roivant Sciences Ltd.

Equities

ROIV

BMG762791017

Other languages

Filters